Today: 3 March 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Meta’s AI Shake-up: 600 Jobs Axed as Zuckerberg Doubles Down on “Superintelligence”

Meta’s AI Shake-up: 600 Jobs Axed as Zuckerberg Doubles Down on “Superintelligence”

Meta will cut about 600 jobs from its Superintelligence Labs, affecting legacy AI teams but sparing the elite TBD Labs group. Chief AI Officer Alexandr Wang told staff the move aims to reduce bureaucracy and boost impact. Meta says AI investment will continue, with recent deals including a $27 billion data center and a $14.3 billion Scale AI stake. Shares trade near $733, up 25% this year, as analysts remain bullish ahead of Q3 earnings.
Quantum Hype Fuels SEALSQ (LAES) Stock Surge – Can It Last?

Quantum Hype Fuels SEALSQ (LAES) Stock Surge – Can It Last?

SEALSQ shares surged nearly 40% on Oct. 9 and 25% on Oct. 14 before retreating to $5.40 by Oct. 22, following major deal announcements and a spike in trading volume. The company raised about $400 million in October and reported 41% revenue growth for the first nine months of 2025. New quantum-security products are slated for launch in 2025 and 2026. Most analysts rate the stock Hold, citing high valuation and execution risks.
Nokia Stock Skyrockets on Major 5G Contracts – Analysts Eye Upside

Nokia Stock Skyrockets on Major 5G Contracts – Analysts Eye Upside

Nokia’s U.S. shares hit a 52-week high of $5.49 on Oct. 14, up 21% over the past month, as investors responded to major 5G contract wins with Vodafone, Rakuten, and Elisa. The company reports Q3 results Oct. 23, with analysts expecting €0.06 EPS on €4.6 billion revenue. Nokia completed a $2.3 billion Infinera takeover and licensed HPE’s AI RAN tech. Rival Ericsson also posted strong Q3 results, intensifying competition.
23 October 2025
QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future

QuantumScape (QS) Stock Rockets on Solid-State Battery Breakthrough – Analysts Split on Future

QuantumScape shares have surged about 170–180% year-to-date, hitting nearly $19 in early October before volatile swings. Q3 net loss was $105.8 million (–$0.18/share), beating estimates, with first-ever customer billings of $12.8 million and $1.08 billion in cash. The company shipped new solid-state battery samples and announced partnerships with Corning and Murata. Most analysts remain cautious, with targets far below current prices.
Meituan (3690.HK) Soars to HK$100: Food-Delivery Wars, AI Ambitions & What Analysts Expect

Meituan (3690.HK) Soars to HK$100: Food-Delivery Wars, AI Ambitions & What Analysts Expect

Meituan shares closed at HK$100.00 on Oct 23, up 4.06% for the day after rebounding from a 52-week low of HK$94.05 last week. The company reported an 89% profit drop in Q2 2025 amid price wars but is expanding overseas and investing heavily in AI. Meituan leads China’s food delivery market with about 70% share. Analysts set a 12-month target of HK$119.7, citing both tech investments and ongoing subsidy battles.
IBM Stock Soars on AI, Cloud and Quantum Momentum

IBM Stock Soars on AI, Cloud and Quantum Momentum

IBM shares rose about 30% in 2025, closing at $287.57 on Oct. 22 before dropping 6.5% after hours following Q3 earnings. The company reported $16.33 billion in revenue, up 9% year-over-year, and adjusted EPS of $2.65, topping forecasts. AI and mainframe sales surged, with the IBM Z mainframe up 61%. IBM raised its full-year revenue outlook to over 5% growth.
Tesla Stock Soars on Record Q3 Deliveries, Profit Miss Raises Concerns

Tesla Stock Soars on Record Q3 Deliveries, Profit Miss Raises Concerns

Tesla delivered a record 497,099 vehicles in Q3 2025, beating forecasts as U.S. buyers rushed to claim expiring EV tax credits. Q3 revenue reached $28.1 billion, but profit margins shrank and adjusted EPS missed estimates. Shares traded near $443 in late October, up about 80% year-to-date. Investors will soon vote on Elon Musk’s proposed $1 trillion pay plan, which faces opposition from proxy adviser ISS.
Nebius Group Explodes 350% on AI Boom – Microsoft Deal and Earnings Next Week in Spotlight

Nebius Group Explodes 350% on AI Boom – Microsoft Deal and Earnings Next Week in Spotlight

Nebius Group shares jumped nearly 350% in 2025, driven by a $17.4 billion AI compute deal with Microsoft that sent the stock up almost 50% in one day. Q3 results will be released Nov. 11, with analysts forecasting a loss of about $0.50 per share. Q2 revenue rose 625% year-over-year to $105.1 million. Wall Street remains bullish, with price targets as high as $137.
Nuburu Stock Soars on New Defense Deals – Price, News, and Expert Analysis

Nuburu Stock Soars on New Defense Deals – Price, News, and Expert Analysis

Nuburu shares tripled to $0.36 by mid-day Oct 22, following a joint venture announcement with Maddox Defense targeting military and commercial drones. The company recently agreed to buy Italy’s Orbit S.r.l. for $12.5 million and secured a $6.6 million order via a new JV with Tekne. Despite recent deals and a $12 million capital raise, Nuburu remains unprofitable, with Q2 revenue at $49,000 and a $12.2 million net loss.
AI Buzz Lifts Pegasystems Stock – Pega Shares Soar on Strong Q3 Results and New Platform Launch

AI Buzz Lifts Pegasystems Stock – Pega Shares Soar on Strong Q3 Results and New Platform Launch

Pega shares rose to $57 on Oct. 21, 2025, after Q3 revenue hit $381.4 million, up 17% year-over-year, and adjusted EPS reached $0.30, beating forecasts. Annual Contract Value climbed 14% to $1.56 billion, with Pega Cloud ACV up 27%. The company generated $347 million in operating cash and repurchased 8.7 million shares this year. Analysts raised price targets, citing strong AI-driven product momentum.
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes will acquire Avadel for $18.50 per share in cash, plus a $1.50 contingent payout, valuing the deal at about $2.1 billion. Avadel’s LUMRYZ sales are projected at $265–$275 million in 2025, with 3,100 patients on therapy. AVDL shares surged to near a 52-week high after the Jazz settlement and Alkermes news. Halper Sadeh LLC is investigating whether the offer undervalues Avadel.
Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol shares surged to $125–$128 in mid-October 2025, up about 80% year-to-date, after Q3 sales jumped 53% to $6.2 billion and EPS rose 86% to $0.93, beating forecasts. The company raised full-year guidance, projecting up to $22.76 billion revenue and $3.28 EPS. Recent acquisitions and strong AI sector demand fueled growth. APH spiked 9% post-earnings, with analysts raising price targets.
Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Applied DNA Sciences (Nasdaq: BNBX) closed a private placement for up to $58 million to fund a BNB-focused digital asset treasury, receiving $27 million immediately. The company now holds over 15,500 BNB tokens and rebranded as BNBX on Oct. 7. BNBX stock rose to $4.49 on Oct. 22, up from $3.42 the previous day. Anthony Scaramucci joined as adviser; Clay Shorrock was named CEO.
Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Arcturus stock hit a 52-week high of $24.17 on Oct. 21 before plunging up to 60% after mixed Phase 2 cystic fibrosis trial results. Interim data showed ARCT-032 was generally safe and reduced lung mucus in most patients, but failed to improve primary lung-function measures. A higher-dose cohort is underway. Analyst ratings remain moderately positive, with price targets averaging $50.
22 October 2025
Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Beneficient stock surged 64% to $0.80 after hours Oct. 21 following Chairman Thomas O. Hicks and Interim CEO James Silk converting $52.6 million of preferred units into Class A shares. The move aims to meet Nasdaq’s minimum equity rules after the company posted a Q1 FY2026 GAAP net loss of $7.19 per share. Zacks maintains a $2.00 price target, but ChartMill rates the company’s fundamentals 1/10.
22 October 2025
Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor shares jumped to a 52-week high of $67.82 on Oct. 21 after Q3 revenue rose 18.5% to $110.4 million and EPS hit $0.63, beating estimates. Analyst upgrades followed, with price targets near $90. The company announced $300 million in licensing deals and launched new high-power modules. Vicor’s market cap stands at $2.9 billion with $362 million in cash and no debt.
1 65 66 67 68 69 140
Go toTop